تريبتورلين

Swine (Sows)

For the synchronization of time of insemination in weaned sows to facilitate a single fixed-time artificial insemination.

Not approved for use in gilts. Safety and effectiveness have not been evaluated in these animals. Should not be used in sows with obvious reproductive tract abnormalities.

OvuGel™

For the synchronization of time of insemination in weaned sows to facilitate a single fixed-time artificial insemination. Not approved for use in gilts. Safety and effectiveness have not been evaluated in these animals.

OvuGel

WITHDRAWAL PERIOD: No withdrawal period is required when used according to labeling. USER SAFETY WARNINGS: Not for Use in Humans. Keep Out of Reach of Children. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. ANIMAL SAFETY WARNINGS: OvuGel® should not be used in sows with obvious reproductive tract abnormalities.

OvuGel®

Swine (Sows)

Administer 200 mcg intravaginally approximately 96 hours after weaning.

Intravaginal

Not approved for use in gilts. Safety and effectiveness have not been evaluated in these animals. Should not be used in sows with obvious reproductive tract abnormalities.

OvuGel™

OvuGel® should be administered intravaginally at approximately 96 hours after weaning. The product should be warmed at room temperature for a minimum of 10 minutes prior to use. Insert the delivery tube into the vagina so that the tip rests 1/2 inch (1-3 cm) posterior to the cervix. Use a separate sheath over the delivery tube for each sow treated. Each sow should receive a single 2 mL dose of OvuGel®. Sows should be inseminated 22 +/- 2 hours following administration of OvuGel® using standard artificial insemination techniques. Sows should be exposed to a boar during time of insemination. (See end of package insert for more detailed directions for OvuGel® administration).

VAGINAL

OvuGel®